NeuroSense Therapeutics Ltd.
NRSNW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001875091
No open-market purchases or sales by NeuroSense Therapeutics Ltd. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $10.4K in total; no superinvestor holds it.
Other share classesNRSN
Superinvestors holding NRSNW, Q2 2026
No superinvestor reported holding NRSNW in Q2 2026.